<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Drug id="87304" name="BOS-172767"><HDS>Phase 1 Clinical</HDS><Actions><Action id="80717" type="primary">Retinoid Z receptor gamma inverse agonist</Action><Action id="1596" type="secondary">Immunomodulator</Action><Action id="2953" type="secondary">Anti-inflammatory</Action><Action id="4805" type="secondary">IL-17 release inhibitor</Action></Actions><Indications><Indication id="36" type="primary">Autoimmune disease</Indication><Indication id="213" type="secondary">Multiple sclerosis</Indication><Indication id="281" type="secondary">Psoriasis</Indication></Indications><Entities><Entity>Chemical</Entity></Entities><OriginatorCompany id="1064824">Arrien Pharmaceuticals LLC</OriginatorCompany></Drug>